Literature DB >> 8376416

Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A.

W Ito1, Y Kurosawa.   

Abstract

In antigen-antibody interactions, the high avidity of antibodies for their specific antigens can be achieved both by exploiting the high affinity of each binding site and by multivalence of antibodies. In this study, we developed artificial antibodies with multiple valency. The Fv fragments of an antibody fused with one and with two domains of the Fc-binding protein A from Staphylococcus aureus (designated Fv-P and Fv-PP, respectively) were expressed in secreted forms in Escherichia coli. Their physical characteristics were examined. The Fv portions of Fv-P and Fv-PP had virtually the same affinity for the antigen as that of the original Fv molecules, and each protein A-derived domain could be bound to IgG. When Fv-P was mixed with IgG, the complex formed was composed of two Fv-P molecules and one IgG molecule. In the case of Fv-PP, a complex composed of three Fv-PP molecules and two IgG molecules was preferentially formed. Analysis of surface plasmon resonance in a BIAcore system indicated multivalency of these complexes for antigens. There was 3.5-fold decrease in the dissociation constant of the complex between Fv-PP and the antigen upon the addition of IgG. The use of these complexes as reagents in enzyme-linked immunosorbent assay and Western blotting gave much stronger signals than Fv, Fv-P, and Fv-PP alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data.

Authors:  D G Myszka; X He; M Dembo; T A Morton; B Goldstein
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

3.  Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport.

Authors:  P Schuck
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

4.  Human neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display.

Authors:  Xiaoping Kang; Bao-An Yang; Yuyang Hu; Hui Zhao; Wei Xiong; Yinhui Yang; Bingyin Si; Qingyu Zhu
Journal:  Clin Vaccine Immunol       Date:  2006-08

5.  Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 6.  Expression of engineered antibodies in plant cells.

Authors:  U Conrad; U Fiedler
Journal:  Plant Mol Biol       Date:  1994-11       Impact factor: 4.076

7.  Detection and characterization of individual intermolecular bonds using optical tweezers.

Authors:  A L Stout
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

8.  The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.

Authors:  Chun Shi Jia; Jiang Ning Liu; Wan Bo Li; Chun Mei Ma; Shu Zhu Lin; Yi Hao; Xue Zhong Gao; Xiao Lin Liu; Yan Feng Xu; Lian Feng Zhang; Chuan Qin
Journal:  Virol J       Date:  2010-02-22       Impact factor: 4.099

9.  Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic.

Authors:  Gene Kurosawa; Yasushi Akahori; Miwa Morita; Mariko Sumitomo; Noriko Sato; Chiho Muramatsu; Keiko Eguchi; Kazuki Matsuda; Akihiko Takasaki; Miho Tanaka; Yoshitaka Iba; Susumu Hamada-Tsutsumi; Yoshinori Ukai; Mamoru Shiraishi; Kazuhiro Suzuki; Maiko Kurosawa; Sally Fujiyama; Nobuhiro Takahashi; Ryoichi Kato; Yoshikazu Mizoguchi; Mikihiro Shamoto; Hiroyuki Tsuda; Mototaka Sugiura; Yoshinobu Hattori; Shuichi Miyakawa; Ryoichi Shiroki; Kiyotaka Hoshinaga; Nobuhiro Hayashi; Atsushi Sugioka; Yoshikazu Kurosawa
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

10.  Comprehensive Identification of Tumor-associated Antigens via Isolation of Human Monoclonal Antibodies that may be Therapeutic.

Authors:  Yoshikazu Kurosawa
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.